Health Canada has issued a recall for certain lots of MAR-Amlodipine 5 mg tablets due to a mix-up that may have led to some bottles containing midodrine 2.5 mg tablets instead.
Health Canada is advising Canadians to check their medications following a recall of two lots of MAR-Amlodipine 5 mg tablets. According to Marcan Pharmaceuticals Inc., certain bottles that are labelled as MAR-Amlodipine may actually contain midodrine 2.5 mg tablets, which are used to treat low blood pressure. This mix-up poses significant health risks, as individuals who take midodrine instead of amlodipine could experience dangerously high blood pressure, dizziness, fainting, slow heartbeats, and in severe cases, potential organ damage.
Particularly vulnerable populations, such as children, may be at an increased risk of harm if they mistakenly consume the incorrect medication. The affected product, MAR-Amlodipine 5 mg with DIN 02371715, comes from two specific lots—2472021 and 2472021A—with an expiry date of July 2027. Health Canada is urging consumers to return any affected medication to their pharmacies and report any adverse effects they may experience from taking the wrong drug.
The recall highlights the critical need for vigilance in medication safety and the importance of proper labeling and quality control in the pharmaceutical industry. The implications of such mix-ups can be severe, emphasizing the need for regulations that ensure patient safety and prevent future occurrences. As the situation develops, Health Canada will likely continue to monitor the impact on public health.
